(Q47284445)

13 January 2018

title

The expression profile of sterile alpha motif and histidine-aspartate domain-containing protein 1 (SAMHD1) in feline tissues (English)

1 reference

13 January 2018

Dorothee Bienzle

3

0 references

author name string

Peyman Asadian

series ordinal

1

1 reference

13 January 2018

Gillian Finnie

series ordinal

2

1 reference

13 January 2018

publication date

11 November 2017

1 reference

13 January 2018

Veterinary Immunology and Immunopathology

published in

1 reference

13 January 2018

volume

195

1 reference

13 January 2018

page(s)

7-18

1 reference

13 January 2018

Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.11.003

SAMHD1-mediated HIV-1 restriction in cells does not involve ribonuclease activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.11.003

Comparison of the effects of retroviral restriction factors involved in resistance to porcine endogenous retrovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.11.003

SAMHD1 restricts HIV-1 infection in resting CD4(+) T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.11.003

Vpx overcomes a SAMHD1-independent block to HIV reverse transcription that is specific to resting CD4 T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.11.003

Nuclease activity of the human SAMHD1 protein implicated in the Aicardi-Goutieres syndrome and HIV-1 restriction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.11.003

Role of SAMHD1 nuclear localization in restriction of HIV-1 and SIVmac

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.11.003

The importance of monocytes and macrophages in HIV pathogenesis, treatment, and cure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.11.003

An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.11.003

The Deoxynucleoside Triphosphate Triphosphohydrolase Activity of SAMHD1 Protein Contributes to the Mitochondrial DNA Depletion Associated with Genetic Deficiency of Deoxyguanosine Kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.11.003

Retrovirus restriction factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.11.003

HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.11.003

Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.11.003

Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.11.003

Mechanism of allosteric activation of SAMHD1 by dGTP

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.11.003

Structural basis of cellular dNTP regulation by SAMHD1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.11.003

Regulation by degradation, a cellular defense against deoxyribonucleotide pool imbalances

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.11.003

Alloimmunity does not protect from challenge with the feline immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.11.003

The ribonuclease activity of SAMHD1 is required for HIV-1 restriction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.11.003

SAMHD1's protein expression profile in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.11.003

HIV-1/HIV-2 versus SAMHD1 restriction: a tale of two viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.11.003

Contribution of SAM and HD domains to retroviral restriction mediated by human SAMHD1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.11.003

The retroviral restriction ability of SAMHD1, but not its deoxynucleotide triphosphohydrolase activity, is regulated by phosphorylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.11.003

A SAMHD1 mutation associated with Aicardi-Goutières syndrome uncouples the ability of SAMHD1 to restrict HIV-1 from its ability to downmodulate type I interferon in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.11.003

Antiviral restriction factor transgenesis in the domestic cat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.11.003

SAMHD1 restricts HIV-1 replication and regulates interferon production in mouse myeloid cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.11.003

Host restriction factors in retroviral infection: promises in virus-host interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.11.003

Structural insight into dGTP-dependent activation of tetrameric SAMHD1 deoxynucleoside triphosphate triphosphohydrolase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.11.003

10.1016/J.VETIMM.2017.11.003

7 January 2021

Identifiers

DOI

1 reference

13 January 2018

release_v7hr5phojbgi7bgwjza5nkctee

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/v7hr5phojbgi7bgwjza5nkctee

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

29249320

1 reference

13 January 2018